A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Clinical trial NCT00277160 · COMPLETED

Trial details

NCT number: NCT00277160
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Neutropenia Breast Cancer Lung Cancer Non-Hodgkin's Lymphoma Ovarian Cancer

Start date: 2002-06-01
Primary completion: 2004-11-01
Enrollment: 852

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.